Literature DB >> 24877900

Comparison of a conventional HIV 1/2 line immunoassay with a rapid confirmatory HIV 1/2 assay.

Caroline Tinguely1, Therese Schild-Spycher1, Zahra Bahador1, Peter Gowland1, Martin Stolz1, Christoph Niederhauser2.   

Abstract

The performance of the rapid confirmatory HIV 1/2 assay Geenius was compared with the conventional HIV 1/2 line immunoblot (INNO-LIA HIV I/II Score). One hundred HIV 1/2 confirmed positive samples from donors and patients and 136 negative screening samples from blood donors were evaluated with both assays. A 20 member performance panel consisting of different HIV 1 and 2 subtypes was also analysed. Ninety-nine of the confirmed HIV positive samples were positive with both assays. One sample was positive with the INNO-LIA HIV I/II Score but indeterminate with the Geenius HIV 1/2. From 136 negative blood donor samples (negative with a combo HIV assay and a highly sensitive ID-NAT), 125 were concordant negative. Six and five samples were incorrectly indeterminate with the INNO-LIA HIV I/II Score and the Geenius HIV 1/2, respectively. One sample was weak positive with the INNO-LIA HIV I/II Score but negative with the Geenius HIV 1/2. The 20 member performance showed equivalent results with both assays. The rapid assay showed a comparable sensitivity and specificity for confirmation for positive and negative HIV donor and patient samples as well for a 20 member performance panel.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Confirmation assays; HIV; Sensitivity; Specificity

Mesh:

Year:  2014        PMID: 24877900     DOI: 10.1016/j.jviromet.2014.05.010

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

Review 1.  Identifying Recent HIV Infections: From Serological Assays to Genomics.

Authors:  Sikhulile Moyo; Eduan Wilkinson; Vladimir Novitsky; Alain Vandormael; Simani Gaseitsiwe; Max Essex; Susan Engelbrecht; Tulio de Oliveira
Journal:  Viruses       Date:  2015-10-23       Impact factor: 5.048

2.  Performance of the HIV Blot 2.2, INNO-LIA HIV I/II Score, and Geenius HIV 1/2 Confirmatory Assay for use in HIV confirmation.

Authors:  Chui Ching Wong; Siew Hoon Lim; Chai Teng Tan; Sook Yin Lui; Yee Leng Lee; Kwai Peng Chan
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

3.  Evaluation of the Bio-Rad Geenius HIV 1/2 Assay as Part of a Confirmatory HIV Testing Strategy for Quebec, Canada: Comparison with Western Blot and Inno-Lia Assays.

Authors:  Bouchra Serhir; Céline Desjardins; Florence Doualla-Bell; Marc Simard; Cécile Tremblay; Jean Longtin
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

4.  Comparative evaluation of the Geenius HIV 1/2 Confirmatory Assay and the HIV-1 and HIV-2 Western blots in the Japanese population.

Authors:  Makiko Kondo; Koji Sudo; Takako Sano; Takuya Kawahata; Ichiro Itoda; Shinya Iwamuro; Yukihiro Yoshimura; Natsuo Tachikawa; Yoko Kojima; Haruyo Mori; Hiroshi Fujiwara; Naoki Hasegawa; Shingo Kato
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

5.  Repeated false reactive ADVIA centaur® and bio-rad Geenius™ HIV tests in a patient self-administering anabolic steroids.

Authors:  Polly Tsybina; Maurice Hennink; Tania Diener; Jessica Minion; Amanda Lang; Stephanie Lavoie; John Kim; Alexander Wong
Journal:  BMC Infect Dis       Date:  2020-01-06       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.